The Grammarly of regulated industries.
A few notes on why I think this is worth building inside Fueled, not somewhere else. Veeva (life sciences)[39] and OneTrust (privacy)[40]both crossed $5B in value by becoming the software regulated companies in their industries ended up having to run. Nothing comparable exists yet for editorial compliance — a review layer that verifies any piece of content — staff-written, agency, or AI-drafted — against the rules its regulator enforces, before it ships.
The SEC and FDA both issued public actions last year against named firms for misleading content; HHS and FINRA pursued significant penalties in the same window. The published Assured AI whitepaper [1] lays out the framework (healthcare-first); this brief extends it to the eight regulated verticals already on assuredai.online.
The Fueled client roster already covers most of them — Mayo Clinic, Cleveland Clinic (1B+ annual health-content visits)[43], Stanford Medicine, KFF, Harvard T.H. Chan, Vida Health, The Florey Institute, WCG Clinical, the White House, California DMV— and ClassifAI is already running inside their editors. Most of the hard parts are already in the building.
Executive summary
Click any tile to jump.
Problem.
Four regulators with active enforcement. SEC + FDA hit named firms for misleading content; HHS + FINRA pursued significant penalties in the same window.Product.
Working reference at assuredai.online. Model-agnostic (OpenAI · Azure · Gemini · Grok · AWS · Ollama-local). WordPress plugin in production; Google Docs Chrome ext in beta. SOC 2 Type I in months 3–4.Traction.
Y1: healthcare + state-level government (BAA at signing, no FedRAMP required). Y2: pharma research, insurance, finance. Y3: legal, real estate, higher ed.Business model.
Two motions. Services — we deliver. SaaS— you operate. Different products, different buyers.To be continued.
The full brief — Year-1 revenue plan, unit economics, assumptions, strategic observations, and the long-horizon platform case — is currently in private review. Available on request.
01 · Problem
Active enforcement, by regulator.
Every firm below ships content through legal and editorial review. The biggest brands still miss things — the rules span thousands of documents, change quarterly, and interact in ways no human reviewer can hold in mind. Below is what got past.
A sample of the firms behind the headlines.
Directly preventable with a verification layer.
Unsupported efficacy claims, missing risk info, untrue statements, missing disclosures, comparative superiority without data. A pre-publish gate catches every category below.
Novartis
FDA OPDP — Kisqali
DTC TV ad claimed Kisqali “preserves quality of life” for breast-cancer patients. The trial didn’t measure that — FDA called the claim misleading.
Kaleo
FDA OPDP — Auvi-Q
Influencer Instagram post promoted Auvi-Q (epinephrine for anaphylaxis) with zero risk information. FDA: a link to safety info isn’t the same as showing the risk.
Mirati / Bristol Myers Squibb
FDA OPDP — Krazati
Healthcare-provider website made composite-endpoint and brain-metastases claims for Krazati. FDA: the lung-cancer trial wasn’t designed to support either claim.
AbbVie
FDA OPDP — Ubrelvy
Serena Williams TV ad oversold Ubrelvy’s migraine benefits. FDA flagged both the unsupported claims and the celebrity-credibility amplification.
Merz Pharmaceuticals
FDA OPDP — Xeomin
Nate Berkus Instagram called Xeomin a “double-filtered smart tox” and a same-day fix. FDA: superiority and timing claims the trials never supported.
Richard Bernstein Advisors
SEC Marketing Rule sweep
Marketing materials cited third-party ratings without the disclosures the SEC Marketing Rule requires. Civil penalty: $295,000.
Abacus Planning Group
SEC Marketing Rule sweep
Ads made untrue statements about third-party ratings — a direct violation of the SEC Marketing Rule. Civil penalty: $150,000.
Exhibit · primary source
What one of these letters actually says.
Excerpts from FDA OPDP’s untitled letter to Novartis re: Kisqali (DTC television advertisement). Highlights added for emphasis; full primary source linked below.
DTC Television Advertisement
MA-297
Dear Mr./Ms. [Redacted]:
The Office of Prescription Drug Promotion (OPDP) of the U.S. Food and Drug Administration (FDA) has reviewed the direct-to-consumer television advertisement (TV ad)1 for KISQALI® (ribociclib) tablets submitted by Novartis Pharmaceuticals Corporation (Novartis) under cover of Form FDA 2253.
The claims that Kisqali “preserves quality of life” and that patients taking the drug are “living well” create a misleading impression that Kisqali has demonstrated a benefit on the patient reported outcome measure of global quality of life. However, the QLQ-C30 global health status / quality of life domain was not designated as a primary or key secondary endpoint in the MONALEESA-2 trial, and the trial was not designed to support claims of improvement in this measure.
The TV ad misbrands Kisqali within the meaning of the Federal Food, Drug and Cosmetic Act (FD&C Act) and makes its distribution violative.
OPDP requests that Novartis cease any violations of the FD&C Act and submit a written response to this letter within 15 working days from the date of receipt, addressing the concerns described herein and listing all promotional communications (with the 2253 submission date) that contain representations like or related to those described in this letter.
Sincerely,
{Signature redacted}
Regulatory Review Officer
Office of Prescription Drug Promotion
152 cases · cumulative
Annual fines · 552 disciplinary actions
Single sweep · 9 firms
Untitled letters · OPDP all-time index
Compounding consequence
The fine is just the tip.
The regulator’s number is the only one with a public dollar figure. Everything beneath the waterline — reputation, litigation, remediation, trust — stacks invisibly, and routinely costs more than the fine itself.
Above the waterline
The fine.
Just below
Reputation damage.
Deeper
Litigation cascade.
Deeper still
Internal remediation.
At the base
Trust erosion.
02 · Why now
Three forces converged.
Any one matters. Together, they created a category that didn’t exist two years ago — and the firm with the customer relationships, not the best model, will own it.
The publishing volume passed human review.
Regulated brands ship more content per day than ever — and the curve is exponential. Product pages, prescribing info, disclosure microsites, emails, chatbot answers. Legal and compliance can review some. Not all.
The rules stopped sitting still.
FDA OPDP, FTC, FINRA, OCR, state AGs — every one of them has updated its enforcement posture in the last eighteen months and signaled more to come. The posture isn’t “publish carefully.” It’s “the rule changed last quarter.” Static playbooks decay in months, not years.
AI took the problem and squared it.
Every regulated brand is shipping AI chatbots, advisors, marketing, disclosure. Each is a new publishing surface — speaking on behalf of the brand without human review. Doubled in size, quadrupled in stakes — in 18 months, not 10 years.
Three incumbents. One open lane.
Veeva, OneTrust, and Grammarly each own a compliance category for their slice of content. The fourth — publishing compliance for regulated teams— has no incumbent. That’s the lane AssuredAI is building.
Fueled has.
A decade of shipping digital products for these companies. The relationships, the trust, the standing — already paid for. The expensive half is done. What’s left is the leverage.
The window
24 months.
After that, someone owns the category. Fueled is that company — or a partner to whoever is.
What category formation looked like for the closest waves.
$1.7B — $26.9BFive categories that took ~10 years to mature. Five primary-source exits, plotted by value. Same window each took to form.
03 · Market
How big is this, vertical by vertical.
US SAM · $1.47B
Eight regulated verticals, sized by addressable revenue.
↑ TAM 2030
$15.8B · 30% CAGR
AI governance software (Forrester). The map below is the addressable subset.
Healthcare
★ Year 1 wedge
$300M
SAM
20.5%
of US total
At 3% capture
$9M / year
~6,100 community hospitals organized into ~400 health systems, plus standalone digital-health platforms and payor publishers shipping HIPAA-bounded content at scale.
Addressable orgs
~6,500
Avg ARR / org
$50,000
SOM · Year-5 capture
Drag to model the capture rate.
Base · 3%
$44M
/ year
Capture % applied to total US SAM. Base case (3%) is the planning number; Conservative (1%) is the floor we underwrite to. Platform-optionality vectors (API for regulated chatbots, multimodal verification, EU AI Act compliance) sit on top of these and are not included.
Same market, by 2030.
$1.47B today → ~$6.5B by 2030 · ~4.4× growthToday’s base, re-sized as AI compliance, EU AI Act, and agentic / multimodal each add their own lines. Hover any 2030 segment for the AI flood inside it and the named players already operating there.
Hover any 2030 segment for the AI flood inside it
International layer
International / EU AI Act
+$1500M
added SAM by 2030
23.1%
of 2030 total
EU AI Act Article 12 (high-risk AI event logging) goes live August 2, 2026. Every high-risk system deployed in or for EU customers needs automatic compliance evidence — a market that did not exist in the US-only base above.
Regulatory anchor
EU AI Act Article 12 (high-risk AI event logging) — effective August 2, 2026. Applies to every high-risk AI system deployed in or for EU customers, regardless of provider HQ.
← Hover any 2030 segment to explore another layer
04 · Product
The architecture.
Five layers, top to bottom. The surfaces writers touch sit on top; the moats — the corpora, the audit chain — sit at the bottom. The verification engine in the middle is the IP every paragraph runs through. Hover any layer for what it actually contains.
Surfaces
Block-editor plugin
Docs · Notion · Substack
Web · public
Sources · kill · escalations
Integration
Verification engine
Model layer
OpenAI · Azure · Gemini · xAI · AWS · open models
Semantic search across approved sources
Industry-tuned identifier scrubbing
Industry-specific rule + claim detectors
Data layer
Per-industry · regulator-grounded
Sub-second semantic search
Cryptographically chained · public-verifiable
Routing · kill-switch · policies
The unifier
Same engine, every surface.
Writers stay in their tools — WordPress, Google Docs, Notion, Substack, Medium. The verification is the same; the surface is whatever the writer already prefers.
The compute
Model-agnostic by design.
Six AI providers plug in. Cloud models for speed; open-source models running inside the customer's data center for environments where data can't leave the building. Customers route which workflow uses which model.
The compounding
The data layer is the moat.
The approved-source knowledge base deepens with every customer and every new industry pack. The tamper-proof audit log becomes the industry standard once it's embedded into enough customers' publishing pipelines. Compounding asset, not a feature.
05 · The warm start
We're not cold-starting.
Most companies in this space burn $5–10M and 18 months on outbound to land one regulated-vertical reference customer. Fueled walks in with twelve — already publishing in our target industries. The cold-start tax is paid.
The twelve accounts we walk in with.
Day 1 · existing Fueled relationships
Twelve accounts across the eight target verticals. All Fueled relationships. Twelve warm intros, not twelve cold calls. Verified at fueled.com/work.
Where we open: Year 1 wedge.
Two verticals · seven warm accountsYear 1 · Healthcare
Anchor account
Supporting warm accounts
Year 1 · Government
Anchor account
Supporting warm accounts
06 · Business model
We deliver the system.
Senior eng + ML + compliance architect. IP transfer at handoff. Not features — finished work.
We deliver ONE vertical pack into ONE editorial workflow. First reference customer in a vertical.
We deliver the full verification system across your org — audit, library, integration, training, rollout.
We operate the system as your dedicated partner — multi-property, BAA / on-prem, dedicated CSM, 99.9% SLA.
Enterprises with complex compliance regimes · multi-property publishers · regulated industries with custom CMS/DAM stacks · Y1 reference customers from the §05 warm-start roster.
You operate the system.
Hosted access to the verification engine + your vertical pack + a self-serve workspace your team configures.
5 writers · 1 vertical pack · 1K verifications/mo · email support. Sign-up to first verification in 15 min.
25 writers · 10K verifications/mo · custom corpus upload · SSO · priority. Mid-market self-serve workspace.
Unlimited writers + verifications · BAA / on-prem · dedicated CSM · multi-pack license · custom dev hours.
Solo editorial teams · mid-market publishers with tech capability · SaaS-native customers from the WP VIP funnel · single-vertical compliance.
A sample, not the full brief.
This brief is part of my application to Fueled. I believe strongly in the AssuredAI opportunity, and the data above is researched and cited. The case itself is a working demonstration — not exhaustive, polished, or final.